The global neurosurgery device market size was valued at USD 14.6 billion in 2025 and is projected to grow from USD 16.53 billion in 2026 to USD 44.56 billion by 2034, registering a CAGR of 13.2% during the forecast period from 2026 to 2034. North America dominated the neurosurgery device market with a market share of 42.5% in 2025.
Neurosurgery devices are specialized medical instruments and equipment used to diagnose, monitor, and treat disorders affecting the brain, spinal cord, and nervous system. These devices include surgical tools, navigation systems, neuroendoscopes, stereotactic equipment, spinal implants, and neuromonitoring technologies that assist surgeons during complex neurological procedures. They are designed to improve surgical precision, enhance patient safety, minimize tissue damage, and support effective treatment of conditions such as brain tumors, spinal disorders, epilepsy, traumatic injuries, and vascular abnormalities.
Download a Free Sample To learn more about this report,
Robotic Navigation Is Expanding in Neurosurgical Procedures
Neurosurgery is increasingly incorporating robotic positioning and navigation technologies to support precise instrument placement during complex procedures. These systems can combine preoperative imaging with robotic positioning to help surgeons establish planned trajectories and guide instruments relative to patient anatomy. The adoption of robotic assistance is supporting neurosurgery device market growth as healthcare providers seek greater precision in minimally invasive and stereotactic procedures.
In January 2025, the U.S. FDA cleared Koh Young Technology's Geniant Cranial, a navigated neurosurgical positioning robot. The Class II device is designed to help neurosurgeons locate anatomical structures and position instrument holders or tool guides during open or percutaneous neurosurgical procedures.
Advanced Digital Visualization Improves Intraoperative Neurosurgery
Neurosurgical visualization is moving toward compact digital systems that combine high-resolution imaging with illumination and surgical instruments. These technologies can provide real-time views of deep or difficult-to-access anatomy while reducing the need for repeated repositioning of conventional visualization equipment. This development is shaping neurosurgery device market trends toward more integrated and minimally invasive visualization solutions.
In July 2025, Viseon reported the first clinical use of its Hubble AV System in neurosurgery during a brain-tumor procedure. The disposable device combines 4K visualization, illumination, and graded suction, providing real-time visualization and access during intracranial procedures.
Increasing Use of Minimally Invasive Brain Therapies
The demand for minimally invasive treatment is supporting adoption of devices that can reach targeted brain regions while limiting disruption to surrounding tissue. Image-guided laser ablation is one example, allowing surgeons to access lesions through very small openings and deliver energy directly to targeted tissue. Such procedures are strengthening neurosurgery device market demand for navigation, imaging, and therapy-delivery systems that support precise intracranial interventions.
In June 2025, Medtronic received FDA 510(k) clearance for its Visualase V2 MRI-Guided Laser Ablation System. The system provides a minimally invasive treatment option for focal epilepsy, brain tumors, and radiation necrosis and incorporates workflow and user-interface improvements into the Visualase platform.
High Capital Requirements for Advanced Neurosurgical Platforms
Advanced neurosurgical devices can require substantial investment in capital equipment, specialized operating-room infrastructure, software, maintenance, and staff training. Facilities must also evaluate whether procedure volumes justify the investment in sophisticated navigation or robotic platforms. These requirements can make adoption more difficult for hospitals with limited capital budgets.
In September 2025, AiM Medical Robotics announced an $8.1 million Series A financing round to advance development of its MRI-compatible robotic neurosurgical platform toward first-in-human trials. The funding illustrates the substantial capital requirements associated with developing and commercializing advanced robotic neurosurgery systems.
Augmented-Reality Navigation Creates New Intraoperative Applications
Augmented-reality navigation is creating opportunities to display patient-specific anatomical information directly within the surgeon's operative field. By spatially aligning imaging data with the patient's anatomy, AR systems can provide trajectory and anatomical guidance while potentially reducing dependence on separate external displays. This creates neurosurgery device market opportunities for companies developing navigation platforms that combine imaging, tracking, and visualization.
In December 2025, Medivis received FDA 510(k) clearance for its Cranial Navigation platform, which the company described as the first AR system cleared for intraoperative guidance in cranial neurosurgery. The platform maps patient imaging into the operative field to provide real-time visualization of anatomy and planned trajectories.
Maintaining Accuracy Across Integrated Navigation and Robotic Systems
Neurosurgical systems increasingly combine imaging, navigation, robotics, and software, creating challenges around registration accuracy, system coordination, workflow integration, and clinical validation. Small positioning errors can have important consequences when procedures involve sensitive brain structures. Manufacturers therefore need to demonstrate reliable performance while ensuring that complex technologies remain practical for surgical teams.
In October 2025, Medical Microinstruments announced completion of the first cases in a clinical trial using its Symani Surgical System for robotic microsurgical intracranial brain surgery. Three adults with Moyamoya disease underwent indirect bypass procedures, providing an early clinical milestone for robotic microsurgery inside the skull.
Neuromodulation Devices Segment Dominated the Neurosurgery Device Market with 76.4% Share in 2025
The neuromodulation devices segment dominated the global neurosurgery device market with a 76.4% share in 2025, driven by the increasing prevalence of neurological disorders such as Parkinson's disease, epilepsy, chronic pain, and movement disorders. Neuromodulation devices help regulate abnormal nerve activity through electrical stimulation, offering minimally invasive and long-term treatment options for patients who do not respond adequately to medication. Continuous technological advancements, growing clinical acceptance, and increasing adoption of implantable neurostimulation systems continue to strengthen the demand for neuromodulation devices.
Within the neuromodulation segment, internal neuromodulation devices continue to account for the largest share due to their widespread use in long-term neurological therapies. Spinal cord stimulation devices remain the dominant internal neuromodulation technology, particularly for managing chronic pain and failed back surgery syndrome, while deep brain stimulation devices are witnessing strong adoption for treating Parkinson's disease, essential tremor, and other movement disorders. External neuromodulation devices also continue to gain traction as non-invasive treatment options for neurological disorders. Meanwhile, the neuroendoscopy devices segment remains an important contributor by enabling minimally invasive diagnosis and treatment of various brain disorders through improved visualization and surgical precision.
Request Customizationto receive a tailored report.
Deep Brain Stimulation Segment is Projected to Register the Fastest Growth in the Neurosurgery Device Market at a CAGR of 8.72%
The deep brain stimulation segment is projected to register the fastest growth in the neurosurgery device market at a CAGR of 8.72% during 2026–2034, driven by increasing adoption of advanced neurostimulation therapies for movement disorders and neurological diseases. Deep brain stimulation has become an effective treatment option for patients with Parkinson's disease, essential tremor, dystonia, and certain psychiatric disorders who experience limited benefits from conventional drug therapies. Ongoing technological advancements, improved surgical outcomes, and expanding clinical indications continue to accelerate the growth of this segment.
The spinal cord stimulation segment continues to account for the largest share of the application market due to its proven effectiveness in treating chronic pain, failed back surgery syndrome, and ischemic pain conditions. Within spinal cord stimulation, chronic pain remains the leading application, followed by failed back surgery syndrome and ischemia. In the deep brain stimulation category, Parkinson's disease represents the largest application, while tremor and depression continue to witness growing adoption as clinical evidence supporting neuromodulation therapies expands. The neuroendoscopy segment also remains an important application area, with transnasal neuroendoscopy accounting for the largest share, followed by intraventricular and transcranial neuroendoscopy procedures that support minimally invasive treatment of complex neurological conditions.
Hospitals Segment Dominated the Neurosurgery Device Market with 68.9% Share in 2025
The hospitals segment dominated the global neurosurgery device market with a 68.9% share in 2025, driven by the availability of advanced neurosurgical infrastructure, highly specialized healthcare professionals, and comprehensive post-operative care facilities. Hospitals perform the majority of complex neurological procedures, including deep brain stimulation, spinal cord stimulation, and neuroendoscopic surgeries, making them the primary users of advanced neurosurgery devices. Increasing investments in neurosurgical technologies and rising volumes of neurological procedures continue to reinforce the dominance of this segment.
The clinics segment continues to witness steady growth as specialized neurology and pain management centers expand access to minimally invasive neuromodulation procedures and follow-up care. Research centers also remain an important contributor to the market by supporting clinical trials, neuroscience research, and the development of next-generation neurosurgical devices. Growing investments in neurological research and innovation continue to accelerate the adoption of advanced neurosurgery technologies across academic and research institutions.
Speak to an Analystto discuss market opportunities.
North America accounted for the largest share of the global neurosurgery device market, representing 42.5% of total revenue and reaching USD 6.21 billion in 2025. The region continues to lead due to the high prevalence of neurological disorders, advanced healthcare infrastructure, and widespread adoption of minimally invasive neurosurgical procedures. Increasing investments in medical technology, growing demand for image-guided surgery, and continuous innovation in robotic-assisted neurosurgery continue to drive market growth across the region.
The US market was valued at approximately USD 5.40 billion in 2025, making it the largest contributor in North America. Rising incidence of brain tumors, stroke, and spinal disorders, increasing adoption of advanced neurosurgical technologies, expanding healthcare expenditure, and ongoing investments in research and development continue to strengthen market growth.
Canada's market reached approximately USD 0.81 billion in 2025. Growing access to advanced neurosurgical procedures, increasing investments in healthcare infrastructure, and rising demand for precision surgical devices are contributing to steady market growth.
Unlock Regional Insightsto access country-level data, & regional trends.
Asia Pacific accounted for 21.4% of the global neurosurgery device market, valued at USD 3.12 billion in 2025, and is projected to register the fastest CAGR of 9.85% during the forecast period. Rising healthcare expenditure, expanding hospital infrastructure, increasing prevalence of neurological disorders, and growing adoption of advanced surgical technologies continue to drive regional market growth. Government initiatives to improve healthcare access and increasing medical tourism are further supporting market expansion.
Japan's market generated approximately USD 0.56 billion in 2025. Strong healthcare infrastructure, increasing adoption of robotic-assisted surgery, and continued investment in advanced medical technologies continue to support market growth.
China accounted for the largest share of the Asia Pacific market, reaching approximately USD 1.87 billion in 2025. Expanding healthcare infrastructure, increasing incidence of neurological diseases, rising investments in medical device manufacturing, and growing adoption of minimally invasive surgical procedures continue to drive market expansion.
Europe accounted for 27.8% of the global neurosurgery device market, reaching USD 4.06 billion in 2025, and is projected to grow at a CAGR of 7.92% during the forecast period. The regional market is supported by advanced healthcare systems, increasing demand for precision surgical procedures, and growing investments in neurosurgical research. Continued technological innovation and favorable reimbursement policies are further strengthening market growth.
The UK market was valued at approximately USD 0.89 billion in 2025. Increasing adoption of advanced neurosurgical equipment, expanding investments in healthcare modernization, and growing demand for minimally invasive procedures continue to support market growth.
Germany's market accounted for approximately USD 1.10 billion in 2025. The country's strong medical device industry, increasing use of image-guided surgical systems, and continued investments in neurological care continue to accelerate market expansion.
Middle East & Africa accounted for 3.7% of the global neurosurgery device market, totaling USD 0.54 billion in 2025. Increasing healthcare investments, expanding access to specialized neurological care, and growing adoption of advanced surgical technologies are supporting market growth across the region. Government initiatives to modernize healthcare infrastructure and improve patient outcomes are expected to create additional opportunities during the forecast period.
The UAE market was valued at approximately USD 0.12 billion in 2025. Rising investments in advanced healthcare facilities, increasing demand for specialized neurosurgical procedures, and expanding adoption of innovative medical devices continue to support market development.
Africa's market reached approximately USD 0.42 billion in 2025. Improving healthcare infrastructure, increasing awareness of neurological disorders, expanding access to specialized surgical care, and rising investments in medical technology are creating long-term growth opportunities across the region.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Aerosol Delivery Devices Market Size, Share, Growth, 2034
Artificial Cornea and Corneal Implant Market Size, Share, 2034
Active Wheelchair Market Size, Share, Growth, Forecast, 2034
Alpha Emitter Market Size, Share, Growth, Analysis, Report, 2034
Advanced Wound Care Market Size, Share, Growth, Analysis, 2034
Acute Wound Care Market Size, Share, Growth, Forecast, 2034
We are featured on:
sales@straitsresearch.com